HomeCompareVNWTF vs JNJ

VNWTF vs JNJ: Dividend Comparison 2026

VNWTF yields 1.66% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $8.2K in total portfolio value· pulled ahead in Year 7
10 years
VNWTF
VNWTF
● Live price
1.66%
Share price
$9.58
Annual div
$0.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.1K
Annual income
$184.93
Full VNWTF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VNWTF vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVNWTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VNWTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VNWTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VNWTF
Annual income on $10K today (after 15% tax)
$141.16/yr
After 10yr DRIP, annual income (after tax)
$157.19/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,828.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VNWTF + JNJ for your $10,000?

VNWTF: 50%JNJ: 50%
100% JNJ50/50100% VNWTF
Portfolio after 10yr
$26.2K
Annual income
$2,437.17/yr
Blended yield
9.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VNWTF
No analyst data
Altman Z
3.4
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VNWTF buys
0
JNJ buys
0
No recent congressional trades found for VNWTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVNWTFJNJ
Forward yield1.66%2.13%
Annual dividend / share$0.16$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$22.1K$30.3K
Annual income after 10y$184.93$4,689.40
Total dividends collected$1.8K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VNWTF vs JNJ ($10,000, DRIP)

YearVNWTF PortfolioVNWTF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,866$166.08$10,592$272.30+$274.00VNWTF
2$11,795$168.65$11,289$357.73+$506.00VNWTF
3$12,792$171.10$12,123$472.89+$669.00VNWTF
4$13,861$173.42$13,141$629.86+$720.00VNWTF
5$15,007$175.62$14,408$846.81+$599.00VNWTF
6$16,235$177.70$16,021$1,151.60+$214.00VNWTF
7← crossover$17,551$179.66$18,122$1,588.22$571.00JNJ
8$18,961$181.52$20,930$2,228.20$2.0KJNJ
9$20,472$183.27$24,792$3,191.91$4.3KJNJ
10$22,090$184.93$30,274$4,689.40$8.2KJNJ

VNWTF vs JNJ: Complete Analysis 2026

VNWTFStock

Vecima Networks Inc. engages in the development of integrated hardware and software solutions for broadband access, content delivery, and telematics. The company operates through three segments: Video and Broadband Solutions, Content Delivery and Storage, and Telematics. The Video and Broadband Solutions segment offers platforms that process data from the cable network and deliver high-speed internet connectivity to homes over cable and fiber, as well as adapt video services. Its principal products include Terrace and TerraceQAM, which are designed to meet the needs of the business services verticals, such as multi-unit dwellings, hotels, motels, and resorts; and Entra distributed access architecture platform comprising EntraPHY, EntraMAC, EntraOptical, EntraControl, and EntraVideo that addresses the network migration to a distributed access architecture. The Content Delivery and Storage segment offers solutions and software for service providers and content owners that focus on ingesting, producing, storing, delivering, and streaming video for live linear, video on demand, network digital video recorder, and time-shifted services over the internet under the MediaScale brand. The Telematics segment provides information and analytics for fleet managers to manage their mobile and fixed assets under the Contigo, Nero Global Tracking, and FleetLynx brands. The company also offers optical access nodes, Terrace TC600E, Terrace IQ, Entra FPXT-B, Entra access controller, Entra access switch, Entra Remote PHY Monitor, Entra Video QAM Manager, MediaScale Origin, MediaScale storage, and MediaScale transcode. In addition, it provides engineering and consultation services; lifecycle program management; installation and commission; training and certification; workforce optimization; and operations and customer support services. The company was incorporated in 1988 and is headquartered in Victoria, Canada. Vecima Networks Inc. is a subsidiary of 684739 B.C. Ltd.

Full VNWTF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VNWTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VNWTF vs SCHDVNWTF vs JEPIVNWTF vs OVNWTF vs KOVNWTF vs MAINVNWTF vs ABBVVNWTF vs MRKVNWTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.